Matinas BioPharma Holdings Inc (MTNB) stock news · $5.6M cap
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
This MTNB news page leads with what Matinas BioPharma Holdings Inc filed — not a scraped headline mill.
No cached 8-K sentence for MTNB yet. We will not pad this page with generic market recap.
Latest reported MTNB revenue for 2023-09-30 was $1.1M. Net income was -$6.1M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. MTNB currently screens at market cap $5.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MTNB stock page; for the tape open the quote page.
MTNB stock news FAQ
What are MTNB's latest revenue and net income?
Latest cached Matinas BioPharma Holdings Inc (MTNB) revenue for Sep 30, 2023 was $1.1M. Net income was -$6.1M. Statements: https://lician.com/financials/mtnb
How did MTNB revenue change from the prior cached period?
Cached Matinas BioPharma Holdings Inc (MTNB) revenue was unchanged from $1.1M (Jun 30, 2023) to $1.1M (Sep 30, 2023). Statements: https://lician.com/financials/mtnb
What is MTNB's market cap?
Matinas BioPharma Holdings Inc (MTNB) market cap is $5.6M on the latest cached fundamentals snapshot.
What kind of company is MTNB?
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Where is MTNB stock news listed?
Cached stock news for Matinas BioPharma Holdings Inc (MTNB) is listed at https://lician.com/news/mtnb. Filings: https://lician.com/sec/mtnb
Not investment advice.